{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Torémifène : Questions médicales les plus fréquentes",
"headline": "Torémifène : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Torémifène : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-22",
"dateModified": "2025-03-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Torémifène"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tamoxifène",
"url": "https://questionsmedicales.fr/mesh/D013629",
"about": {
"@type": "MedicalCondition",
"name": "Tamoxifène",
"code": {
"@type": "MedicalCode",
"code": "D013629",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.150.700.900"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Torémifène",
"alternateName": "Toremifene",
"code": {
"@type": "MedicalCode",
"code": "D017312",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Alexander N Stukov",
"url": "https://questionsmedicales.fr/author/Alexander%20N%20Stukov",
"affiliation": {
"@type": "Organization",
"name": "Department of Innovative Methods of Therapeutic Oncology and Rehabilitation, N. N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russia."
}
},
{
"@type": "Person",
"name": "Mikhail A Osipov",
"url": "https://questionsmedicales.fr/author/Mikhail%20A%20Osipov",
"affiliation": {
"@type": "Organization",
"name": "Department of Innovative Methods of Therapeutic Oncology and Rehabilitation, N. N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russia."
}
},
{
"@type": "Person",
"name": "Tatjana Y Semiglazova",
"url": "https://questionsmedicales.fr/author/Tatjana%20Y%20Semiglazova",
"affiliation": {
"@type": "Organization",
"name": "Department of Innovative Methods of Therapeutic Oncology and Rehabilitation, N. N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russia."
}
},
{
"@type": "Person",
"name": "Larisa V Filatova",
"url": "https://questionsmedicales.fr/author/Larisa%20V%20Filatova",
"affiliation": {
"@type": "Organization",
"name": "Department of Innovative Methods of Therapeutic Oncology and Rehabilitation, N. N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russia."
}
},
{
"@type": "Person",
"name": "Valerij A Alexandrov",
"url": "https://questionsmedicales.fr/author/Valerij%20A%20Alexandrov",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Cancer Chemoprevention and Oncopharmacology, N. N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Device innovation in cardiovascular medicine: a report from the European Society of Cardiology Cardiovascular Round Table.",
"datePublished": "2024-02-16",
"url": "https://questionsmedicales.fr/article/38366821",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/eurheartj/ehae069"
}
},
{
"@type": "ScholarlyArticle",
"name": "Advanced Heart Failure: Therapeutic Options and Challenges in the Evolving Field of Left Ventricular Assist Devices.",
"datePublished": "2024-02-16",
"url": "https://questionsmedicales.fr/article/38392275",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/jcdd11020061"
}
},
{
"@type": "ScholarlyArticle",
"name": "A 3D-printed hollow microneedle-based electrochemical sensing device for in situ plant health monitoring.",
"datePublished": "2024-02-13",
"url": "https://questionsmedicales.fr/article/38367566",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bios.2024.116131"
}
},
{
"@type": "ScholarlyArticle",
"name": "Interface fails and Young's module approximation of multilayer flexible devices through finite element method.",
"datePublished": "2024-02-10",
"url": "https://questionsmedicales.fr/article/38375298",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.heliyon.2024.e26257"
}
},
{
"@type": "ScholarlyArticle",
"name": "Computer-Aided Discrimination of Glaucoma Patients from Healthy Subjects Using the RETeval Portable Device.",
"datePublished": "2024-02-06",
"url": "https://questionsmedicales.fr/article/38396388",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/diagnostics14040349"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hydrocarbures",
"item": "https://questionsmedicales.fr/mesh/D006838"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrocarbures cycliques",
"item": "https://questionsmedicales.fr/mesh/D006844"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hydrocarbures aromatiques",
"item": "https://questionsmedicales.fr/mesh/D006841"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dérivés du benzène",
"item": "https://questionsmedicales.fr/mesh/D001555"
},
{
"@type": "ListItem",
"position": 7,
"name": "Composés benzylidéniques",
"item": "https://questionsmedicales.fr/mesh/D001597"
},
{
"@type": "ListItem",
"position": 8,
"name": "Stilbènes",
"item": "https://questionsmedicales.fr/mesh/D013267"
},
{
"@type": "ListItem",
"position": 9,
"name": "Tamoxifène",
"item": "https://questionsmedicales.fr/mesh/D013629"
},
{
"@type": "ListItem",
"position": 10,
"name": "Torémifène",
"item": "https://questionsmedicales.fr/mesh/D017312"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Torémifène - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Torémifène",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Torémifène",
"description": "Comment le torémifène est-il prescrit ?\nQuels tests précèdent la prescription de torémifène ?\nLe torémifène est-il utilisé pour d'autres cancers ?\nQuels marqueurs tumoraux sont surveillés ?\nLe torémifène nécessite-t-il un suivi régulier ?",
"url": "https://questionsmedicales.fr/mesh/D017312?mesh_terms=Lab-On-A-Chip+Devices&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Torémifène",
"description": "Quels sont les effets secondaires courants du torémifène ?\nLe torémifène cause-t-il des douleurs articulaires ?\nY a-t-il des symptômes d'allergie au torémifène ?\nLe torémifène affecte-t-il l'humeur ?\nQuels symptômes nécessitent une consultation immédiate ?",
"url": "https://questionsmedicales.fr/mesh/D017312?mesh_terms=Lab-On-A-Chip+Devices&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Torémifène",
"description": "Le torémifène est-il utilisé en prévention du cancer ?\nQuelles sont les recommandations préventives ?\nLe mode de vie influence-t-il l'efficacité du torémifène ?\nY a-t-il des alternatives au torémifène pour la prévention ?\nLe torémifène est-il efficace chez les femmes jeunes ?",
"url": "https://questionsmedicales.fr/mesh/D017312?mesh_terms=Lab-On-A-Chip+Devices&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Torémifène",
"description": "Comment le torémifène est-il administré ?\nQuelle est la posologie standard du torémifène ?\nLe torémifène peut-il être combiné avec d'autres traitements ?\nCombien de temps dure un traitement au torémifène ?\nLe torémifène nécessite-t-il des ajustements de dose ?",
"url": "https://questionsmedicales.fr/mesh/D017312?mesh_terms=Lab-On-A-Chip+Devices&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Torémifène",
"description": "Quelles complications peuvent survenir avec le torémifène ?\nLe torémifène augmente-t-il le risque de cancer de l'utérus ?\nComment gérer les complications du torémifène ?\nLe torémifène peut-il causer des problèmes cardiaques ?\nQuels signes indiquent une complication grave ?",
"url": "https://questionsmedicales.fr/mesh/D017312?mesh_terms=Lab-On-A-Chip+Devices&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Torémifène",
"description": "Quels sont les facteurs de risque pour le cancer du sein ?\nLe surpoids est-il un facteur de risque ?\nLes antécédents familiaux influencent-ils le risque ?\nLe tabagisme est-il un facteur de risque ?\nL'âge de la première menstruation influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D017312?mesh_terms=Lab-On-A-Chip+Devices&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment le torémifène est-il prescrit ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est prescrit pour traiter le cancer du sein hormono-dépendant chez les femmes."
}
},
{
"@type": "Question",
"name": "Quels tests précèdent la prescription de torémifène ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests hormonaux et des biopsies peuvent être effectués pour évaluer le cancer."
}
},
{
"@type": "Question",
"name": "Le torémifène est-il utilisé pour d'autres cancers ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est principalement utilisé pour le cancer du sein, mais des études explorent d'autres indications."
}
},
{
"@type": "Question",
"name": "Quels marqueurs tumoraux sont surveillés ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux d'œstrogènes et de récepteurs hormonaux sont souvent surveillés."
}
},
{
"@type": "Question",
"name": "Le torémifène nécessite-t-il un suivi régulier ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est essentiel pour évaluer l'efficacité et les effets secondaires."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires courants du torémifène ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent bouffées de chaleur, nausées et fatigue."
}
},
{
"@type": "Question",
"name": "Le torémifène cause-t-il des douleurs articulaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines patientes rapportent des douleurs articulaires comme effet secondaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes d'allergie au torémifène ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réactions allergiques peuvent survenir, comme éruptions cutanées ou démangeaisons."
}
},
{
"@type": "Question",
"name": "Le torémifène affecte-t-il l'humeur ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines patientes peuvent éprouver des changements d'humeur ou de l'anxiété."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent une consultation immédiate ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques, des saignements inhabituels ou des symptômes allergiques graves."
}
},
{
"@type": "Question",
"name": "Le torémifène est-il utilisé en prévention du cancer ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est parfois utilisé pour réduire le risque de cancer du sein chez les femmes à risque élevé."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations préventives ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les femmes à risque élevé devraient discuter des options de prévention avec leur médecin."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il l'efficacité du torémifène ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain peut améliorer l'efficacité du traitement et réduire les risques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des alternatives au torémifène pour la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "D'autres options incluent les inhibiteurs de l'aromatase et les interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "Le torémifène est-il efficace chez les femmes jeunes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut être efficace, mais les décisions doivent être basées sur des évaluations individuelles."
}
},
{
"@type": "Question",
"name": "Comment le torémifène est-il administré ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est généralement administré par voie orale sous forme de comprimés."
}
},
{
"@type": "Question",
"name": "Quelle est la posologie standard du torémifène ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La posologie standard est souvent de 60 mg par jour, mais peut varier selon le cas."
}
},
{
"@type": "Question",
"name": "Le torémifène peut-il être combiné avec d'autres traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être utilisé en association avec d'autres thérapies comme la chimiothérapie."
}
},
{
"@type": "Question",
"name": "Combien de temps dure un traitement au torémifène ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement peut varier, souvent plusieurs mois à plusieurs années."
}
},
{
"@type": "Question",
"name": "Le torémifène nécessite-t-il des ajustements de dose ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des ajustements peuvent être nécessaires en fonction des effets secondaires et de la réponse."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec le torémifène ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des thromboses veineuses profondes peuvent survenir."
}
},
{
"@type": "Question",
"name": "Le torémifène augmente-t-il le risque de cancer de l'utérus ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut augmenter le risque de cancer de l'utérus chez certaines patientes."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications du torémifène ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion implique un suivi régulier et des ajustements de traitement si nécessaire."
}
},
{
"@type": "Question",
"name": "Le torémifène peut-il causer des problèmes cardiaques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des problèmes cardiaques sont rares mais peuvent survenir, nécessitant une surveillance."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication grave ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques, des saignements vaginaux ou des symptômes neurologiques."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour le cancer du sein ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, les antécédents familiaux et l'exposition aux œstrogènes."
}
},
{
"@type": "Question",
"name": "Le surpoids est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le surpoids et l'obésité augmentent le risque de cancer du sein et d'autres cancers."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancer du sein augmentent le risque individuel."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme est associé à divers cancers, y compris le cancer du sein."
}
},
{
"@type": "Question",
"name": "L'âge de la première menstruation influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une menstruation précoce peut augmenter le risque de cancer du sein plus tard."
}
}
]
}
]
}
Research performed in Europe has driven cardiovascular device innovation. This includes, but is not limited to, percutaneous coronary intervention, cardiac imaging, transcatheter heart valve implantat...
Heart Failure is a chronic and progressively deteriorating syndrome that has reached epidemic proportions worldwide. Improved outcomes have been achieved with novel drugs and devices. However, the num...
Plant health monitoring is devised as a new concept to elucidate in situ physiological processes. The need for increased food production to nourish the growing global population is inconsistent with t...
Electronic flexible devices are prone to degrade their electrical performance or lose functionality when subjected to deformations. Brittle fracture is a common damaging effect observed in devices com...
Glaucoma is a chronic, progressive eye disease affecting the optic nerve, which may cause visual damage and blindness. In this study, we present a machine-learning investigation to classify patients w...
The real-world data on the safety profile of transvenous lead extraction (TLE) for infected cardiac implantable electronic devices (CIED) among elderly patients is not well-established. This study aim...
Using the Nationwide Readmissions Database, our study included patients aged ≥18 years who underwent TLE for infected CIED between 2017 and 2020. We divided the patients into four groups: Group A. You...
A total of 10,928 patients who were admitted for TLE of infected CIED were included in this study: 982 (9.0%) patients in group A, 4,234 (38.7%) patients in group B, 3,204 (29.3%) patients in group C ...
Elderly patients had worse in-hospital outcomes in early mortality and non-home discharge following the TLE for infected CIED. There was no significant difference between elderly and non-elderly group...
Embolic protection devices are useful for preventing distal embolism during carotid artery stenting (CAS); however, complications have been reported. The successful removal of a filter fragment trappe...
CAS was performed for internal carotid artery stenosis in a patient in his 70s, and the carotid stent was successfully placed. During the retrieval procedure, the tip of the filter was trapped at the ...
The edge of a carotid stent can potentially trap devices. When trapping or fragmentation of a device is suspected, it is necessary to evaluate the situation and cause, and the device should be appropr...
The use of an antibacterial envelope is cost-effective for patients at high risk of developing cardiac implantable electronic device (CIED) infection. The identification of these high-risk patients ma...
This was a retrospective single-center study of consecutive patients undergoing a CIED procedure between January 2016 and November 2021. Patients who received an antibacterial envelope were excluded f...
A total of 2333 CIED procedures were performed in the study period (mean age 61.6 ± 16.3 years, male sex 64.5%, previous CIED infection 1.7%, immunocompromised 5.4%). The median PADIT score was 4 (int...
The PADIT score is a clinically useful score for identifying patients at high risk of developing CIED infection. The use of an antibacterial envelope in these high-risk patients may be cost-effective....
Solid organ and vascularized composite allograft transplantation are pivotal in enhancing both life expectancy and quality of life. However, the significant risk of donor tissue rejection requires lif...
Atomically precise hydrogen desorption lithography using scanning tunnelling microscopy (STM) has enabled the development of single-atom, quantum-electronic devices on a laboratory scale. Scaling up t...